Loncastuximab

Tax included
Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL).
MedChemExpress 
HY-P99711

Data sheet

Size
Multiple sizes
Reactivity
CD19
Application
Cancer-programmed cell death
CAS
1875032-68-0